NDC 35573-414
Methocarbamol
Methocarbamol
Methocarbamol is a Oral Tablet, Coated in the Human Prescription Drug category. It is labeled and distributed by Burel Pharmaceuticals, Inc.. The primary component is Methocarbamol.
| Product ID | 35573-414_14e20dbc-f4b4-11e9-802a-5aa538984bd8 |
| NDC | 35573-414 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Methocarbamol |
| Generic Name | Methocarbamol |
| Dosage Form | Tablet, Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-09-30 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA209312 |
| Labeler Name | Burel Pharmaceuticals, Inc. |
| Substance Name | METHOCARBAMOL |
| Active Ingredient Strength | 750 mg/1 |
| Pharm Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |